Introduction
Porcine reproductive and respiratory syndrome (PRRS), causing late-term reproductive failure and severe pneumonia in neonatal pigs, continues to have an economically significant impact on the swine industry worldwide. Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped single stranded positive-sense RNA virus classified in the order Nidovirales, the family Arteriviridae, and the genus Arterivirus [3, 6] . The viral genomic RNA contains at least nine open reading frames (ORFs)-ORF1a, ORF1b, ORFs 2 (2a and 2b), ORF3 and 4 and ORF5s (5a and 5b) to 7, as well as the 5 0 and 3 0 untranslated regions [2, 11, 18, 26] . ORF1a and ORF1b generate at least 14 nonstructural proteins (Nsps) by autocatalytic processing. ORF1a encodes Nsp1a, Nsp1b, Nsp2-Nsp6, Nsp7a, Nsp7b and Nsp8, and ORF1b encodes Nsp9-Nsp12 [4, 9, 14, 21] . Among the nonstructural proteins of PRRSV, Nsp2 is the largest part of the cleavage product of the replicative protein. The Nsp2 protein of PRRSV can be divided into three major domains: the conserved N-terminal cysteine proteinase domain (PLP2/OTU), a hydrophobic transmembrane region at the C terminus; a large hypervariable domain (HV); and a transmembrane domain (TM), which are located between the former two domains [5, 10, 22, 23] . Porcine reproductive and respiratory syndrome virus (PRRSV) was divided into North American and European genotypes [1] . The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) that emerged in 2006, shares an identical discontinuous deletion of 30 amino acids (aa) in Nsp2 [13, 15, 29] . The TJM-F92 vaccine strain derived from the HP-PRRSV TJ strain by passage 92 times in the African green monkey kidney epithelial cell line Marc-145 has an additional 120-aa deletion in Nsp2 [24, 25] .The additional 120-aa deletion in Nsp2 (aa 628-747) located between the HV1 and HV2 regions in a relatively conserved region of Nsp2 [12] . The nucleotide protein (NP), encoded by the PRRSV ORF7 gene is considered to be one of the most conserved PRRSV proteins [17] . In addition, NP has rich antigenic determinants, which induce production of long-time antibodies after the PRRSV infects cells. NP has good immunogenicity and reaction activity [8, 20, 27, 28] .
In recent decades, highly specific monoclonal antibodies (MAbs) have been exploited to provide reliable diagnoses for many diseases. The MAbs have monovalent affinity due to their binding to the same epitope, and can specially recognize antigenic. MAbs are important tool in biochemistry, molecular biology and medicine. MAbs are also very useful for identification and antigenic characterization of pathogens in animal disease diagnosis. Here we produced MAbs against PRRSV NP and PRRSV Nsp2-120aa. The MAbs against PRRSV NP can be used to diagnose PRRS, and can identify all of the North American genotype PRRSV strains. The MAbs raised against Nsp2-120aa can be used to differentiate PRRSV infection from the vaccine inoculation of TJM-F92 in pigs.
Materials and methods
Cells, animals, viruses and plasmids E. coli strains (DH5a)and BL21 (DE3) were purchased from TRANSGEN BIOTECH. Marc-145 cells and Mouse myeloma cells (Sp2/0) were purchased from ATCC. Marc-145 cells were cultured in MEM medium (Gibco, USA), 1% solution of antibiotics (streptomycin and penicillinSangon Biotech), and 10% fetal bovine serum (FBSGibco). Sp2/0 cells were maintained in IMDM medium (Invitrogen, USA) with 15% FBS. Cells were cultured at 37°C and 5% CO 2 . Balb/c mice were obtained from the Animal Centre of Peking University Health Science Center. PRRSV JL-04/12 was a HP-PRRSV isolated in 2012. PRRSV TJM-F92 was a commercial vaccine strain. We made use of a series of prokaryotic expression plasmids constructed by Liu et al. [16] : Nsp2 (628-727), Nsp2 (628-707), Nsp2 (628-707), Nsp2 (648-747), Nsp2 (668-747), Nsp2 (688-747) were. The expression plasmids pGEX-NP and pGEX-dNsp2, expressing PRRSV NP and Nsp2-120aa respectively, were constructed by our research group using standard cloning methods.
Bacterial expression and purification of N and Nsp2-120aa recombinant protein pGEX-NP and pGEX-dNsp2 were transformed into E. coli BL-21 cells and expression of the NP and Nsp2-120aa induced with 0.1 mmol/L isopropyl-b-d-thiogalactoside (IPTG). Expression of the NP and Nsp2-120aa proteins was confirmed by sodium dodecyl sulfate polyacrylamide gelelectrophoresis (SDS-PAGE) and western blotting. The proteins were purified using a B-PER (tm) GST Purification Kit (Thermo, USA) according to the manufacturer's instructions.
Immunization of the animals
Four mice were inoculated on day zero with two subcutaneous doses of 0.05 mL containing 60 lg concentrated NP or Nsp2-120aa, diluted 1:1 in Freund's Incomplete Adjuvant into the footpad of the hind legs. Three subsequent booster inoculations were made at half doses at 14 day intervals. Antibody titers were determined by enzyme-linked immunosorbent assay (ELISA) from 10 to 36 days after the first booster. The mice with the highest antibody titers were chosen for cell fusion. A fourth booster immunization was given to the chosen mice with 50 lg of pathogen by intraperitoneal injection 3 days before cell fusion.
Production of monoclonal antibodies from hybridoma cell
Cell fusion was performed three days after the last immunization. Mouse myeloma Sp2/0 cells were cultured and propagated in RPMI-1640 culture medium (Gibco) and 10% fetal bovine serum (FBS) (Gibco). First, collecting growth well Sp2/0 cells, and cells transferred into a 50 ml centrifuge tube. The mice were euthanasia and soaked for 5 min in 75% alcohol. The thymocyte were isolated from the immunized mouse and mixed with the Sp2/0 cells at a ratio of 5:1 in IMDM free FBS, 2 ml of HAT was added, followed by centrifugation at 1500 rad/min for5 min. The supernatant was discarded and cells gently resuspended with IMDM free FBS for washing. Then, 1 ml of PEG was slowly added to the cells under 37°C warm water and stood for 1 min. Ten milliliters of IMDM free FBS was added within 2 min (2 ml initially, then a further 8 ml), followed by centrifugation at 1000 rad/min for 5 min. The cells were carefully resuspended in 10 ml FBS after pouring away the supernatant and then added to the prepared thymus cells. Sterile semi-solid medium (25 ml) was added and divided into culture dishes. The cells were cultured in a hot and humid incubator.
Characterization of monoclonal antibodies
Monoclonal antibody (Mab) isotypes were determined by enzyme linked immunosorbent assay (ELISA) using a mouse isotyping primary antibody (Southern Biotech) and various subtype secondary antibodies (Southern Biotech). PBS with 2% BSA and 3% sucrose was used as a blocking solution. Ten microliters of 30% H 2 O 2 and 0.2 ml H 2 O with 15 mg/ml diammonium salt were added into 10 ml of sodium citratehydrochloric acid buffer as color-substrate solution.
Reactivity of MAbs with PRRSV Screening testindirect immunofluorescence
The chosen MAbs were screened using indirect immunofluorescence (IFA). High pathogenic PRRSV JL-04/12 and vaccine strain TJM-F92 were inoculated in Marc-145 cells. After 48 h, the cells were fixed with 70% ethyl alcohol. The hybridoma supernatant of NP and Nsp2-120aa were used as primary antibody and goat anti-mouse IgG Labeled HRP as secondary antibody. The antibody incubation times were 45 min at 37°C. The results were observed under fluorescence microscope (Leca, Japan).
Western blotting confirm the binding activity of MAbs and PRRSV
To verify the reactivity against recombinant proteins and PRRSV, the supernatants of the obtained stable cell clones were tested by western blotting, using recombinant proteins and PRRSV JL-04/12 and TJM-F92 cell cultural lysates as antigens. The antigens were resolved by 12% SDS-PAGE and transferred onto 0.22 lm PVDF membrane (Millipore, USA)at room temperature and 5 mA for 2 h. The membrane was blocked with 5% skimmed milk in PBS-T overnight at 4°C. The culture supernatants of the desired hybridoma cells were added as the primary antibodies. The horseradish peroxidase (HRP) conjugated goat anti-mouse IgG antibody (Sigma, USA) served as the secondary antibody, whose HRP activity was detected using an Enhanced ECL chemilumine scence detection kit (concentrated) (Vazyme, China).
Peptide identification of MAbs of Nsp2-120aa
A series of prokaryotic expression plasmids [Nsp2 (628-727), Nsp2 (628-707), Nsp2 (628-707), Nsp2 (648-747), Nsp2 (668-747) and Nsp2 (688-747)] were transfected into Marc-145 cells. At 36 h after transformation, the cells were fixed with 70% ethyl alcohol. Then IFA was done to figure out which plasmid will act with the chosen MAbs. So we can verified the corresponding sequence of MAb.
Purification of MAbs
BALb/c mice were injected with 0.5 ml incomplete Freund's adjuvant in the abdominal cavity 1 week in advance. Then, the thrive hybridoma were centrifuged and the culture medium discarded. Cells were resuspended in PBS or incomplete medium and injected into the abdominal cavity of the mice. Seven to 10 days later, ascitic fluid was sucked from the enlarged abdomen with a syringe and centrifuged to remove impurities (e.g., cells, protein and fat). The MAbs were purified using a Protein A IgG Purification Kit (Thermo Fisher Scientific, USA) following the manufacturer's instructions. We were able to recover MAbs with relatively high purity and good antibody activity.
Affinity determination of MAbs
We determined the affinity constant of the MAbs using competition ELISA. The antigen was coated with (citratebuffered saline) CBS at 2 lg/ml and the hybridoma supernatant of the MAbs diluted from 1:200 to 1:204,800. The antigens were gradient diluted two times. The diluted MAbs were mixed with an equal volume of the corresponding diluted antigens and incubating for 20 h at room temperature. The mixture was added into the wells of a 96-well plate and incubated for 30 min at 37°C. After three washes with PBS-T, then added secondary antibody diluted to 1:10,000, and incubated for 30 min at 37°C. Following a further three washes, the substrate TMB was added and incubated for 10 min. The action was stopped with 0.5 M H 2 SO4. The optical density (OD) was detected using a BIO-RAD Microplate reader. The affinity constant was calculated using the formula (150,000 9 A)/original concentration of the MAb.
Results

Production and characterization of the MAbs against PRRSV NP or Nsp2-120aa
The mouse with higher antibody titer were chosen and splenocytes were sterile collected and fused with sp2/0 cells. Thirty-two clones of NP (of 930 wells tested) and 23 clones of Nsp2-120aa (of 930 wells tested) tested positive by ELISA. In order to further determine the positive clones, further ELISA using PRRSV NP (for MAb of NP) or Nsp2-120aa (for MAb of Nsp2-120aa) and GST as antigens were performed. Eighteen hybridomas of NP and 11 hybridomas of Nsp2-120aa were selected. NP MAbs were characterized as 7 IgG2b and 8 IgG1 of the kappa light chain. Nsp2-120aa MAbs were characterized as 6 IgG2a, 1 IgG2b and 4 IgG1. The clone data are listed in supplementary tables 1 and 2. 
One epitope domain of Nsp2-120aa MAbs was determined
Mapping of the 6 six epitopes was performed using a panel of expressed polypeptides: Nsp2 (628-727), Nsp2 (628-707), Nsp2 (628-707), Nsp2 (648-747), Nsp2 (668-747) and Nsp2 (688-747) (Fig. 1a) . The polypeptide Nsp2 (628-727) could be recognized by all 5 MAbs of Nsp2-120aa chosen in this study (Fig. 2a) . Interestedly, four transiently expressed polypeptides: Nsp2 (628-727), Nsp2 (648-747), Nsp2 (668-747) and Nsp2 (688-747) were all recognized by MAb #13 of Nsp2-120aa (Fig. 2a,  b) .The overlapping epitope polypeptide sequence was (707) GRFEFLPKMILETPPPHPCG(727). We named this MAb BR/PNsp2-2A20.
MAbs binding activity with antigens or PRRSV by Western blotting
The recombinant proteins, HP-PRRSV JL-04/12 and PRRSV vaccine strain TJM-F92 were used as antigens during western blotting. The corresponding MAbs were used as the primary antibodies. Our data show that the MAbs against PRRSV NP strongly bind to the NP expressed by HP-PRRSV and the vaccine strain in Marc-145 cells (Fig. 3a) . The corresponding MAbs of PRRSV Nsp2-120aa also had a strong binding activity with Nsp2-120aa. These data indicate that the MAbs recovered here were targeting the correct epitopes of the recombinant proteins. However, no apparent expected reaction band was seen when probing PRRSV strains with the MAbs raised against PRRSV Nsp2-120aa (Fig. 3b) .
Purification and affinity determination of MAbs
We had purified the four MAbs against either PRRSV NP or Nsp2-120aa. The size is right and purity is good by SDS-PAGE detection (Fig. 4a, d) . From the affinity curve, we obtained the affinity constant for each MAb. The affinity constant of #29 and #13 PRRSV NP MAbs are 8.99E ? 09 and 7.93E ? 09, respectively (Fig. 4b, c) . The affinity constant of the No. 13 and No. 14 PRRSV Nsp-120aa MAbs were estimated as 2E ? 06 and 5E ? 09, respectively (Fig. 4e, f) .
Discussion
MAbs directed against a single epitope should be homogeneous, highly specific and producible in unlimited quantities. MAbs generally exhibit exquisite specificity for the target antigen. In this study, we constructed are combinant expressed vector for the PRRSV NP and Nsp2-120aa. The recombinant proteins were successfully recovered from E.coli BL-21 and purified. The purified recombinant proteins were inoculated mice. After three rounds of screening by ELISA and IFA, we identified two NP MAbs (#13 and 29) and five Nsp2-120aa MAbs (#8, 13, 14, 15, 17) . MAb subtype data indicated that we had obtained two G2b subtype NP MAbs and two G1 and 3 G2a subtype Nsp2-120aa MAbs. IFA data demonstrated that 2 MAbs raised against the NP have a positive reaction to PRRSV; either HP-PRRSV, classic PRRSV or the vaccine strain. All five Nsp2-120aa MAbs (#8, 13, 14, 15, 17) exhibited immunoreactivity with the denatured Nsp2-120aa recombinant protein in Western blotting and two MAbs produced strong cell membrane staining in PRRSV infected MARC-145 cells in an immunofluorescence assay. Two MAbs raise against Nsp2-120aa also react positively with the classic PRRSV nor HP-PRRSV, but not with the PRRSV vaccine strain TJM-F92.
All MAbs against NP and Nsp2-120aa showed good binding activity against the native PRRSV virion when analyzed by IFA, as well as clear reactivity with the corresponding recombinant proteins in western blotting.
However, we did not find an reaction in Western blotting between MAbs of Nsp2-120aa and PRRSV JL-04/12 collected from Marc-145 cells. We propose that this result may be because of non-structural protein being expressed during the early period of virus replication, which is quickly degraded.
The epitope mapping of Nsp2-120aa was done by serial truncation of the Nsp2-120aa protein and identified Nsp- MAb BR/PNsp2-2A20. The amino acid sequence is 20aa: (707) GRFEFLPKMILETPPPHPCG(727). Based on our findings, we propose that MAb BR/PNsp2-2A20, raised against Nsp2-120aa of PRRSV, as a candidate specific diagnostic MAb for differentiation of the PRRSV virulent strains infected pig from vaccine strain TJM-F92 inoculated ones.
A previous research has shown thatVR2385-R, with a large spontaneous deletion of 145 aa of the Nsp2 gene, has an overlapping region in its deletion (aa 581-725) [19] with the TJM-F92 deleted 120aa (aa 628-747). We previously suggested the aa 727-747 of Nsp2 were most likely related to PRRSV's replication ability [25] . Now, in this study, we had obtained a MAb against a peptide corresponding to another region (aa 707-727). This peptide is located between the HV1 and HV2 regions. Previous research has shown that Nsp2 has 18 B cell linear epitopes and that these are scattered along the Nsp2 amino acid sequence [7] . The peptide sequence (707) GRFEFLPK-MILETPPPHPCG(727) recognized by MAb BR/PNsp2-2A20 is not included in the 18 B-cell linear epitopes. It is a novel epitope peptide found in this study.
In summary, the purified MAbs reacted well with recombinant proteins and PRRSV. The affinity constants of these MAbs were calculated by ELISA and all shown to have a high affinity for the antigens, except #13 MAb against Nsp2-120aa. These MAbs can now be used applied in the future development of diagnostic methods. Here we obtained two MAbs against PRRSV NP and five MAbs against PRRSV Nsp2-120aa. By IFA using transiently expressed truncated proteins, we identified the peptide targeted by the MAb BR/PNsp2-2A20. MAbs were purified in preparation for future experiment. 
